BCA
XTNT icon

Berman Capital Advisors’s Xtant Medical Holdings XTNT Stock Holding History

Berman Capital Advisors’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-140,838
Closed -$126K – 1797
2020
Q2 		$126K Buy
+140,838
New +$129K 0.03% 195

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Berman Capital Advisors's XTNT Position: Q3 2020 in Review

Berman Capital Advisors sold out of Xtant Medical Holdings (XTNT) in Q3 2020, closing a stake of 140,838 shares — an estimated $126K sold.

Berman Capital Advisors first reported a position in XTNT in Q2 2020 and held it in 1 quarter. The position peaked at $126K in Q2 2020. 20 funds tracked by Wall St. Rank hold XTNT as of Q3 2020.

  • Berman Capital Advisors reported no remaining Xtant Medical Holdings position as of Q3 2020 after selling out during the quarter.
  • Berman Capital Advisors sold 140,838 Xtant Medical Holdings shares in Q3 2020, an estimated $126K.
  • Berman Capital Advisors first reported a position in Xtant Medical Holdings in Q2 2020 and held it in 1 quarter.
  • Berman Capital Advisors's Xtant Medical Holdings position peaked at $126K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2020.

Based on Berman Capital Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.